Transfection of the type I TGF-β receptor restores TGF-β responsiveness in pancreatic cancer

International Journal of Cancer

Volumn 78, Issue 2, 1998, Pages 255-260

  Wagner, Markus ^a   Kleeff, Jörg ^a   Lopez, Martha E ^a   Bockman, Irene ^a   Massaqué, Joan ^b   Korc, Murray ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; DOSE RESPONSE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL; REPORTER GENE; SEQUENCE ANALYSIS;

ACTIVIN RECEPTORS, TYPE I; CELL DIVISION; DNA-BINDING PROTEINS; HUMANS; IMMUNOBLOTTING; MUTATION; PANCREATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD4 PROTEIN; TRANS-ACTIVATORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0031694080     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981005)78:2<255::AID-IJC21>3.0.CO;2-8     Document Type: Article

References (39)

1. ARTEAGA, C.J., CARTY-DUGGER, T., MOSES, H.L., HERD, S.D. and PIETENPOL, J.L., Transforming growth factor-β1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice. Cell Growth Differentiation, 4, 193-201 (1993).
2. ATTISANO, L., CÁRCAMO, J., VENTURA, F., WEIS, P.M.B., MASSAGUÉ, J. and WRANA, J.L., Identification of human activin and TGF-β type I receptors that form heteromeric kinase complexes with type II receptors. Cell, 75, 671-680 (1993).
3. BAE, H.W., GEISER, A.G., KIM, D.H., CHUNG, M.T., BURMESTER, J.K., SPORN, M.B., ROBERTS, A.B. and KIM, S.-J., Characterization of the promoter region of the human transforming growth factor-β type II receptor gene. J. biol. Chem., 270, 29460-29468 (1995).
4. BALDWIN, R.L., FRIESS, H., YOKOYAMA, M., LOPEZ, M.E., KOBRIN, M.S., BÜCHLER, M.W. and KORC, M., Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition. Int. J. Cancer, 67, 283-288 (1996).
5. BALDWIN, R.L. and KORC, M., Growth inhibition of human pancreatic carcinoma cells by transforming growth factor beta-1. Growth Factors, 8, 23-34 (1993).
6. BLOOM, B.B., HUMPHRIES D.E., KUANG, P.-P., FINE, A. and GOLDSTEIN, R.H., Structure and expression of the promoter for the R4/ALK5 human type I transforming growth factor-β receptor: regulation by TGF-β. Biochim. biophys. Acta, 1312, 243-248 (1996).
7. BOYER, J.C., UMAR, A., RISINGER, J.I., LIPFOR, J.R., KANE, M., YIN, S., BARRETT J., KOLODNER, R.D. and KUNKEL, T.A., Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines. Cancer Res., 55, 6063-6070 (1995).
8. CÁRCAMO, J., WEIS, F.M.B., VENTURA, F., WIESER, R., WRANA, J.L., ATTISANO, L. and MASSAGUÉ, J., Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor β and activin. Mol. cell. Biol., 14, 3810-3821 (1994).
9. FRIESS, H., YAMANAKA, Y., BÜCHLER, M., BEGER, H.G., KOBRIN, M.S., BALDWIN, R.L. and KORC, M., Enhanced expression of the type II transforming growth factor-beta receptor in human pancreatic cancer cells without alteration of type III receptor expression. Cancer Res., 53, 2704-2707 (1993a).
10. FRIESS, H., YAMANAKA, Y., BÜCHLER, M., EBERT, M., BEGER, H.G., GOLD, L.I. and KORC, M., Enhanced expression of transforming growth factor-β isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology. 105, 1846-1856 (1993b).
11. GOGGINS, M., SCHUTTE, M., LU, J., MOSKALUK, C.A., WEINSTEIN, C.L., PETERSEN, G.M., YEO, C.J., JACKSON, C.E., LYNCH, H.T., HRUBAN R.H., and KERN, S.E., Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res., 56, 5360-5364 (1996).
12. GORSCH, S.M., MEMOLI, V.A., STUKEL, T.A., GOLD, L.I. and ARRICK, B.A., Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer. Cancer Res., 52, 6949-6952 (1992).
13. GRAU, A.M., ZHANG, L., WANG, W., EVANS, D.B., ABBRUZZESE, J.L., ZHANG, W. and CHIAO, P.J., Induction of p21waf1 expression and growth inhibition by transforming factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells. Cancer Res., 57, 3929-3934 (1997).
14. HELDIN, C.-H., MIYAZONO, K. and TEN DUKE, K., TGF-β signalling from cell membrane to nucleus trough SMAD proteins. Nature (Lond.), 390, 465-471 (1997).
15. HUANG, L., GOODROW, T.L., ZHANG, S.Y., KLEIN-SZANTO, A.J., CHANG, H. and RUGGERI, B.A., Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas. Cancer Res., 56, 1137-41 (1996).
16. JI, CH., CASINGHINO, S., MCCARTHY, T.L. and CENTRELLA, M., Cloning, characterization, and expression of the transforming growth factor-β type I receptor promoter in fetal rat bone cells. J. cell. Biochem., 63, 478-490 (1996).
17. JI, CH., CASINGHINO, S., MCCARTHY, T.L. and CENTRELLA, L., Multiple and essential binding sites in the promoter for transforming growth factor-β type I receptor. J. biol. Chem., 272, 21260-21267 (1997).
18. KADIN, M.E., CAVAILLE-COLL, M.W., GERTZ, R., MASSAGUÉ, J., CHEIFETZ, S. and GEORGE, D., Loss of receptors for transforming growth factor β in human T cell malignancies. Proc. nat. Acad. Sci. (Wash.), 91, 6002-6006
19. KIM, I.Y., AHN, H.J., ZELNER, D.J., SHAW, J.W., SENSIBAR, J.A., KIM, J.H., KATO, M. and LEE, C., Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells. Cancer Res., 56, 44-48 (1996).
20. KLEEFF, J: and KORC, M., Up-regulation of transforming growth factor-β receptors by TGF-β1 in COLO-357 cells. J. biol. Chem., 273, 7495-7500 (1998).
21. KLOEN, P., GEBHARDT, M.C., PEREZ-ATAYDE, A., ROSENBERG, A.E., SPRINGFIELD, D.S., GOLD, L.I. and MANKIN, H.J., Expression of transforming growth factor-beta (TGF-beta) isoformes in osteosarcomas: TGF-beta3 is related to disease progression. Cancer, 80, 2230-2239 (1997).
22. KORC, M., Role of growth factors in pancreatic cancer. Surg. Clin. North Amer., 7, 25-41 (1998).
23. LAGNA, G., HATA, A., HEMMATI-BRIVANTOU, A. and MASSAGUÉ, J., Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways. Nature (Lond.), 383, 832-836 (1996).
24. MARKOWITZ, S., WANG, J., MEYERHOFF, L., PARSONS, R., SUN, L., LUTTER-BAUGH, J., FAN, R.S., ZBOROWSKA, E., KINZLER, K.W., VOGELSTEIN, B., BRATTAIN, M. and WILSON, J.K.V., Inactivation of the TGF-β type II receptor in colon cancer cells with microsatellite instability. Science, 268, 1336-1338 (1995).
25. MASSAGUÉ, J., The transforming growth factor-beta family. Ann. Rev. Cell Biol., 6, 597-641 (1990).
26. MEYERHOFF, L.L. and 17 OTHERS, A transforming growth factor-β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res., 55, 5545-5547 (1995).
27. MORETTI, S., PINZI, C., BERTI, E., SPALLANZANI, A., CHIARUGI, A., BODDI, V., REALI, U.M. and GIANNOTTI, B., In situ expression of transforming growth factor beta is associated with melanoma progression and correlates with Ki67. HLA-DR and beta 3 integrin expression. Melanoma Res., 7, 313-321 (1997).
28. NAKAMORI, S., YASHIMA, K., MURAKAMI, Y., ISHIKAWA, O., OHIGASHI, H., IMAOKA, S., YAEGASHI, S., KONISHI, Y. and SEKIYA, T., Association of p53 gene mutations with short survival in pancreatic adenocarcinoma. Jpn. J. Cancer Res., 86, 174-81 (1995).
29. OKAMOTO, M. and OYASU, R., Overexpression of transforming growth factor β type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line. Cell Growth Differentiation, 8, 921-926 (1997).
30. PARK, K., KIM, S.-J., BANG, Y.-J., PARK, J.-G., KIM, N.K., ROBERTS, A.B. and SPORN, M.B., Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc. nat. Acad. Sci. (Wash.), 91, 8722-8766 (1994).
31. PELLEGATA, N.S., SESSA, F., RENAULT, B., BONATO, M., LEONE, B.E., SOLCIA, E. and RANZANI, G.N., K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res., 54, 1556-1560 (1994).
32. SCHUTTE, M. and 14 OTHERS, DPC4 gene in various tumor types. Cancer Res., 56, 2527-2530 (1996).
33. SPORN, M.B. and ROBERTS, A.B., Transforming growth factor-β: recent progress and new challenges. J. Cell Biol., 119, 1017-1021 (1992).
34. STEINER, M.S. and BARRACK, E.R., Transforming growth factor-β overproduction in prostate cancer: effects on growth in vivo and in vitro. Mol. Endocrinol., 6, 15-25 (1992).
35. TAKANAMI, I., TANAKA, F., HASHIZUME, T., KIKUCHI, K., YAMAMOTO, Y., YAMAMOTO, T. and KODAIRA, S., Transforming growth factor-beta isoforms expression in pulmonary adenocarcinomas as prognostic markers: an immunohistological study of one hundred and twenty patients. Oncology, 54, 122-128 (1997).
36. TEN DUKE, P., YAMASHITA, H., ICHIJO, H., FRANZÉN, P., LAIHO, M., MIYAZONO, K. and HELDIN, H., Characterization of type I receptors for transforming growth factor beta and activin. Science, 264, 101-104 (1994).
37. WANG, J., HAN, W., ZBOROWSKA, E., LIANG, J., WANG, X., WILLSON, J.K.V., SUN, L. and BRATTAIN, M.G., Reduced expression of transforming growth factor β type I receptor contributes to the malignancy of human colon carcinoma cells. J. biol. Chem., 271, 17366-17371 (1996).
38. WRANA, J.L., ATTISANO, L., CÁRCAMO, J., ZENTELLA, A., DOODY, J., LAIHO, M., WANG, X.F. and MASSAGUÉ, J., TGF beta signals through a heteromeric protein kinase receptor complex. Cell, 71, 1003-14 (1992).
39. WRANA, J.L., ATTISANO, L., WISER, R., VENTURA, F. and MASSAGUÉ, J., Mechanism of activation of the TGF-β receptor. Nature (Lond.), 370, 341-347 (1994).